961 Clinical Trials for: Hodgkin Lymphoma, Page 1 of 49

Page 1 of 49 1 2 3 » 5 10 15 … Last Page »

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Condition(s): Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma Last Updated: November 20, 2012Recruiting

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Condition(s): Hodgkin Lymphoma; Lymphoma Last Updated: July 5, 2012Completed

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Condition(s): HIV Infection; HIV-associated Hodgkin Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage IV Adult Hodgkin Lymphoma Last Updated: January 16, 2013Not yet recruiting

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine- Based Treatment.

Condition(s): Hodgkin Lymphoma Last Updated: February 15, 2013Active, not recruiting

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

Condition(s): Hodgkin's Disease Last Updated: April 21, 2011Recruiting

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Condition(s): Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma Last Updated: May 1, 2013Recruiting

Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic

Condition(s): Hodgkin's Disease Last Updated: April 15, 2013Recruiting

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Condition(s): Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification Last Updated: November 24, 2010Completed

Gonadal Toxicity in Women With Hodgkin Lymphoma

Condition(s): Hodgkin Lymphoma Last Updated: November 11, 2009Recruiting

Induction Chemotherapy w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Condition(s): Hodgkin Lymphoma, Adult Last Updated: April 23, 2013Recruiting

Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma

Condition(s): Recurrent Adult Hodgkin Lymphoma Last Updated: March 14, 2013Recruiting

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Condition(s): Hodgkin Disease; Hodgkin Lymphoma Last Updated: May 1, 2013Recruiting

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Condition(s): Hodgkin Lymphoma Last Updated: December 13, 2012Active, not recruiting

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

Condition(s): Hodgkin Lymphoma; Hodgkin Disease Last Updated: January 7, 2013Completed

Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma

Condition(s): Hodgkin Lymphoma Last Updated: May 14, 2013Recruiting

Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes

Condition(s): Hodgkin's Lymphoma Last Updated: April 11, 2012Recruiting

Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma

Condition(s): Hodgkin Lymphoma Last Updated: January 23, 2013Recruiting

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Condition(s): Relapsed or Refractory Hodgkin Lymphoma Last Updated: April 1, 2013Recruiting

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Condition(s): Hodgkin's Lymphoma Last Updated: October 29, 2012Recruiting

Page 1 of 49 1 2 3 » 5 10 15 … Last Page »

ClinicalTrialsFeeds.org

NIH Clinical Trials Results via RSS

961 Clinical Trials for: Hodgkin Lymphoma, Page 1 of 49

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine- Based Treatment.

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Gonadal Toxicity in Women With Hodgkin Lymphoma

Induction Chemotherapy w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma

Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes

Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Get These Results via Email or RSS

Subscribe via Web Newsreaders

Clinical Trials by Condition

Clinical Trials by Drug

Clinical Trials for Rare Diseases

Clinical Trials of Dietary Supplements

Clinical Trials by Sponsor

Clinical Trials by Location

About Clinical Trials Research

Site Details

961 Clinical Trials for: Hodgkin Lymphoma, Page 1 of 49

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine- Based Treatment.

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Gonadal Toxicity in Women With Hodgkin Lymphoma

Induction Chemotherapy w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma

Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes

Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Share Clinical Trials

Get These Results via Email or RSS

Subscribe via Web Newsreaders

Clinical Trials by Condition

Clinical Trials by Drug

Clinical Trials for Rare Diseases

Clinical Trials of Dietary Supplements

Clinical Trials by Sponsor

Clinical Trials by Location

About Clinical Trials Research

Site Details